Through analysis via the GEO database and examination of tissues from DLBCL patients, it was evident that both ALKBH5 and IGF2BP2 were highly expressed in DLBCL patients compared with normal controls. The gene discussed is IGF2BP2; the disease is diffuse large B-cell lymphoma.